2019
DOI: 10.1007/s43441-019-00015-3
|View full text |Cite
|
Sign up to set email alerts
|

A Quantitative Study of US FDA Inspection Data for Drug Manufacturing Sites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…Macher et al (2006) investigated how different factors, such as days between inspection, compliance history, and the quality of training of the inspectors, impact the classification a facility receives. Similarly, Pazhayattil et al (2020) explored how violations of different sections of the CGMP were correlated with the inspection classifications. Hein et al (2019) compared various data-driven methods to predict the classification facilities would receive.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Macher et al (2006) investigated how different factors, such as days between inspection, compliance history, and the quality of training of the inspectors, impact the classification a facility receives. Similarly, Pazhayattil et al (2020) explored how violations of different sections of the CGMP were correlated with the inspection classifications. Hein et al (2019) compared various data-driven methods to predict the classification facilities would receive.…”
Section: Literature Reviewmentioning
confidence: 99%
“…donijeti odluku o ukidanju proizvodne dozvole, ukidanju ili suspendiranju rješenja za stavljanje lijeka u promet, narediti povlačenje lijeka/djelatne tvari/ pomoćne tvari iz prometa ili obustavu njihova isporučivanja na teritoriju Republike Hrvatske, odnosno propisati druge regulatorne mjere). [19][20][21][22][23] Na temelju provedene inspekcije, izvješća i dostavljenog očitovanja o nedostatcima, inspektor izrađuje završni izvještaj i mišljenje o ispunjavanju uvjeta dobre proizvođačke prakse, temeljem kojeg se izdaje rješenje o davanju/ uskraćivanju/ izmjeni/ ukidanju proizvodne dozvole, rješenje o davanju ili uskraćivanju upisa/izmjene upisa u očevidnik ili rješenje o brisanju iz očevidnika proizvođača, uvoznika i veleprodaja djelatnih i/ili pomoćnih tvari, ili davanju potvrde o provođenju dobre proizvođačke prakse (GMP potvrda), odnosno u slučaju neispunjavanja uvjeta izdaje se Rješenje i Izjava o neispunjavanju uvjeta dobre proizvođačke prakse (engl. Non-Compliance).…”
Section: Provođenje Gmp Nadzoraunclassified